You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Fluidigm this week launched its EP1 system for high-throughput SNP genotyping and digital PCR.
Using Fluidigm’s dynamic arrays, the system can provide up to 9,216 data points per IFC chip with results in just four hours. The system includes the firm’s IFC Controller, Stand Alone Thermal Cycler and End Point Reader, and can provides over 27,000 genotypes a day.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.
Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.
The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.
In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.